Published in Biol Open on March 22, 2013
Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt. Front Cell Dev Biol (2017) 0.75
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell (2008) 16.72
The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry (1968) 9.00
Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care (2001) 2.75
AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med (2008) 2.16
Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell Mol Life Sci (2007) 1.87
The coordination of nuclear and mitochondrial communication during aging and calorie restriction. Ageing Res Rev (2009) 1.79
Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med (2009) 1.72
Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res (2007) 1.67
Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am J Physiol Cell Physiol (2000) 1.32
What determines the intracellular ATP concentration. Biosci Rep (2003) 1.28
Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes (2009) 1.17
Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis. Dev Med Child Neurol (2009) 1.15
Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state. Am J Physiol Heart Circ Physiol (2000) 1.11
Metabolic and histologic effects of sodium pyruvate treatment in the rat after cortical contusion injury. J Neurotrauma (2009) 1.10
Comparative study of protein and mRNA expression during osteoclastogenesis. Proteomics (2005) 1.02
Osteoclast precursors display dynamic metabolic shifts toward accelerated glucose metabolism at an early stage of RANKL-stimulated osteoclast differentiation. Cell Physiol Biochem (2007) 1.01
AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts. Bone (2010) 1.00
Regulation of osteoclastic bone resorption by glucose. Biochem Biophys Res Commun (1997) 1.00
Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function. FASEB J (2009) 0.99
THE FINE STRUCTURE OF BONE CELLS. J Biophys Biochem Cytol (1961) 0.99
Artefacts in cell culture: pyruvate as a scavenger of hydrogen peroxide generated by ascorbate or epigallocatechin gallate in cell culture media. Biochem Biophys Res Commun (2009) 0.98
Breast cancer-derived factors stimulate osteoclastogenesis through the Ca2+/protein kinase C and transforming growth factor-beta/MAPK signaling pathways. J Biol Chem (2009) 0.92
Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors. Cell Death Differ (2005) 0.92
Ascorbic acid accelerates osteoclast formation and death. Bone (2009) 0.89
Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases. J Cell Biochem (2007) 0.88
Pyruvate modulates antioxidant status of cultured human lens epithelial cells under hypergalactosemic conditions. Mol Cell Biochem (2002) 0.80
Regulation of cancer cell migration and bone metastasis by RANKL. Nature (2006) 5.27
Fibrillin-1 interactions with fibulins depend on the first hybrid domain and provide an adaptor function to tropoelastin. J Biol Chem (2007) 1.56
Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival. Cancer Res (2002) 1.52
Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils. J Biol Chem (2002) 1.39
Osteoconduction and osteoinduction of low-temperature 3D printed bioceramic implants. Biomaterials (2007) 1.26
Fibrillins: from biogenesis of microfibrils to signaling functions. Curr Top Dev Biol (2006) 1.20
Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2. J Biol Chem (2006) 1.15
Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway. Bone (2007) 1.09
Silver-doped calcium phosphate cements with antimicrobial activity. Acta Biomater (2011) 1.06
Ionic modification of calcium phosphate cement viscosity. Part I: hypodermic injection and strength improvement of apatite cement. Biomaterials (2004) 1.04
CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone. Am J Pathol (2011) 0.99
Matrigel improves functional properties of human submandibular salivary gland cell line. Int J Biochem Cell Biol (2011) 0.99
Biologically mediated resorption of brushite cement in vitro. Biomaterials (2005) 0.98
Consequences of cysteine mutations in calcium-binding epidermal growth factor modules of fibrillin-1. J Biol Chem (2004) 0.97
Craniofacial vertical bone augmentation: a comparison between 3D printed monolithic monetite blocks and autologous onlay grafts in the rabbit. Biomaterials (2009) 0.96
Mathematical modeling of spatio-temporal dynamics of a single bone multicellular unit. J Bone Miner Res (2009) 0.95
Influence of calcium phosphate crystal assemblies on the proliferation and osteogenic gene expression of rat bone marrow stromal cells. Biomaterials (2006) 0.94
Biocompatibility of magnesium phosphate minerals and their stability under physiological conditions. Acta Biomater (2011) 0.93
Mathematical modeling in bone biology: from intracellular signaling to tissue mechanics. Bone (2010) 0.92
The effect of amorphous pyrophosphate on calcium phosphate cement resorption and bone generation. Biomaterials (2013) 0.92
Breast cancer-derived factors stimulate osteoclastogenesis through the Ca2+/protein kinase C and transforming growth factor-beta/MAPK signaling pathways. J Biol Chem (2009) 0.92
In vitro biodegradation of three brushite calcium phosphate cements by a macrophage cell-line. Biomaterials (2006) 0.91
Accelerated mineralization of dense collagen-nano bioactive glass hybrid gels increases scaffold stiffness and regulates osteoblastic function. Biomaterials (2011) 0.90
Magnesium-sputtered titanium for the formation of bioactive coatings. Acta Biomater (2009) 0.90
The importance of particle size and DNA condensation salt for calcium phosphate nanoparticle transfection. Biomaterials (2008) 0.89
Rapamycin inhibits osteolysis and improves survival in a model of experimental bone metastases. Cancer Lett (2011) 0.89
Ascorbic acid accelerates osteoclast formation and death. Bone (2009) 0.89
Passive and active in vitro resorption of calcium and magnesium phosphate cements by osteoclastic cells. Tissue Eng Part A (2010) 0.89
Complex dynamics of osteoclast formation and death in long-term cultures. PLoS One (2008) 0.88
Minimally invasive maxillofacial vertical bone augmentation using brushite based cements. Biomaterials (2008) 0.88
Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis. Bone (2010) 0.87
Brushite-collagen composites for bone regeneration. Acta Biomater (2008) 0.87
Egr-1 negatively regulates calsequestrin expression and calcium dynamics in ventricular cells. Cardiovasc Res (2008) 0.87
The use of RANKL-coated brushite cement to stimulate bone remodelling. Biomaterials (2008) 0.87
Influence of powder/liquid mixing ratio on the performance of a restorative glass-ionomer dental cement. Biomaterials (2003) 0.87
ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone. Breast Cancer Res (2012) 0.86
Osteoprotegerin in bone metastases: mathematical solution to the puzzle. PLoS Comput Biol (2012) 0.86
Strontium modified biocements with zero order release kinetics. Biomaterials (2008) 0.85
Modification of the structure and function of fibrillin-1 by homocysteine suggests a potential pathogenetic mechanism in homocystinuria. J Biol Chem (2005) 0.85
Modeling vancomycin release kinetics from microporous calcium phosphate ceramics comparing static and dynamic immersion conditions. Acta Biomater (2008) 0.85
Osteoclast precursors acquire sensitivity to breast cancer derived factors early in differentiation. Bone (2008) 0.84
Collagen biomineralization in vivo by sustained release of inorganic phosphate ions. Adv Mater (2010) 0.84
Preparation of tricalcium phosphate/calcium pyrophosphate structures via rapid prototyping. J Mater Sci Mater Med (2008) 0.84
Characterization of chlorhexidine-releasing, fast-setting, brushite bone cements. Acta Biomater (2008) 0.83
Alendronate affects calcium dynamics in cardiomyocytes in vitro. Vascul Pharmacol (2009) 0.83
Silk fibroin derived polypeptide-induced biomineralization of collagen. Biomaterials (2011) 0.83
Factors influencing calcium phosphate cement shelf-life. Biomaterials (2005) 0.83
An airway smooth muscle cell niche under physiological pulsatile flow culture using a tubular dense collagen construct. Biomaterials (2012) 0.83
Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. J Control Release (2007) 0.82
Phase composition, mechanical performance and in vitro biocompatibility of hydraulic setting calcium magnesium phosphate cement. Acta Biomater (2009) 0.82
In vitro transfer of keratinocytes: comparison of transfer from fibrin membrane and delivery by aerosol spray. J Biomed Mater Res B Appl Biomater (2005) 0.82
Antimicrobial potency of alkali ion substituted calcium phosphate cements. Biomaterials (2005) 0.82
Chemical characterization of a degradable polymeric bone adhesive containing hydrolysable fillers and interpretation of anomalous mechanical properties. Acta Biomater (2009) 0.82
Mesenchymal stem cell-seeded multilayered dense collagen-silk fibroin hybrid for tissue engineering applications. Biotechnol J (2011) 0.81
Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin. Breast Cancer Res Treat (2013) 0.81
Breast cancer at bone metastatic sites: recent discoveries and treatment targets. J Cell Commun Signal (2011) 0.81
Fibrillin-1 directly regulates osteoclast formation and function by a dual mechanism. J Cell Sci (2013) 0.81
Molecular structure and interaction of recombinant human type XVI collagen. J Mol Biol (2004) 0.80
The effect of autoclaving on the physical and biological properties of dicalcium phosphate dihydrate bioceramics: brushite vs. monetite. Acta Biomater (2012) 0.80
Three-dimensional mineralization of dense nanofibrillar collagen-bioglass hybrid scaffolds. Biomacromolecules (2010) 0.80
Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase. J Biol Chem (2010) 0.79
Frozen delivery of brushite calcium phosphate cements. Acta Biomater (2008) 0.79
Melatonin dietary supplement as an anti-aging therapy for age-related bone loss. Rejuvenation Res (2014) 0.79
Comparison of the effects of serpin A1, a recombinant serpin A1-IGF chimera and serpin A1 C-terminal peptide on wound healing. Peptides (2007) 0.79
Reproducible quantification of osteoclastic activity: characterization of a biomimetic calcium phosphate assay. J Biomed Mater Res B Appl Biomater (2013) 0.79
Erythropoietin-dependent endothelial proteins: potential use against erythropoietin resistance. Cytokine (2010) 0.79
Bioactivity of bone resorptive factor loaded on osteoconductive matrices: stability post-dehydration. Eur J Pharm Biopharm (2008) 0.78
Chaperonin 10 as an endothelial-derived differentiation factor: role of glycogen synthase kinase-3. J Cell Physiol (2009) 0.78
Vertical bone augmentation with 3D-synthetic monetite blocks in the rabbit calvaria. J Clin Periodontol (2011) 0.78
Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro Osteoclast Differentiation in Arthritis study. Arthritis Rheum (2013) 0.77
Deconvolution of calcium fluorescent indicator signal from AFM cantilever reflection. Microsc Microanal (2012) 0.77
The optimisation of the initial viscosity of an encapsulated glass-ionomer restorative following different mechanical mixing regimes. J Dent (2005) 0.76
CD4+ effector T cell distribution in vivo: TGF-beta 1/TGF-beta receptor II interaction during activation mediates accumulation in the target tissue by preferential proliferation. Eur J Immunol (2004) 0.76
Low temperature fabrication of spherical brushite granules by cement paste emulsion. J Mater Sci Mater Med (2012) 0.76
Biological activities and molecular interactions of the C-terminal residue of thrombospondin-4, an epitome of acidic amphipathic peptides. Peptides (2009) 0.76
Localized experimental bone metastasis drives osteolysis and sensory hypersensitivity at distant non-tumor-bearing sites. Breast Cancer Res Treat (2015) 0.76
Antimicrobial properties of nanocrystalline tetracalcium phosphate cements. J Biomed Mater Res B Appl Biomater (2007) 0.75
Monocyte proliferation and differentiation to osteoclasts is affected by density of collagen covalently bound to a poly(dimethyl siloxane) culture surface. J Biomed Mater Res A (2012) 0.75
Electropolymerized carbonic anhydrase immobilization for carbon dioxide capture. Langmuir (2014) 0.75
Sustained steroid release in pulmonary inflammation model. Biomaterials (2010) 0.75
A new class of bioactive glasses: calcium-magnesium sulfophosphates. J Biomed Mater Res A (2013) 0.75
Ultrasonic phosphate bonding of nanoparticles. Adv Mater (2013) 0.75
Electrocatalytic Oxygen Reduction Performance of Silver Nanoparticle Decorated Electrochemically Exfoliated Graphene. Langmuir (2015) 0.75